Risk Factors in Breast Cancer Progression and Current Advances in Therapeutic Approaches to Knockdown Breast Cancer

@inproceedings{Amjad2018RiskFI,
  title={Risk Factors in Breast Cancer Progression and Current Advances in Therapeutic Approaches to Knockdown Breast Cancer},
  author={A. M. Amjad and Iqra Khan and Zarfashan Kausar and Fatima O. Saeed and Laraib azhar and Pervez Anwar},
  year={2018}
}
The complicated coding of tumorous cells requires emerging molecular biology tools for early diagnosis and for the better understandings of cancer progression. In spite of the advancement in diagnostic and therapeutic approaches to hit breast cancer, it is still a second major cause of cancerous deaths among women globally. In therapeutic vibes, deregulation in the expression of genes such as BRCA1, BRCA2, PIK3, RB, MDM2, TPK53 and HER2 involved in breast cancer prevalence. Furthermore… 

Figures and Tables from this paper

COMPREHENSIVE REVIEW ON ETIOPATHOGENESIS, TREATMENT AND EMERGING THERAPIES OF BREAST CANCER
  • Arun Kumar
  • Biology, Medicine
    Asian Journal of Pharmaceutical and Clinical Research
  • 2021
TLDR
The present review summarized and compiled the complete information of BC about its molecular pathogenesis, biomarkers, staging system, emerging therapies, and current advancement of BC.
Nanotechnology to Cure Breast Cancer and Obstacles in its Way
TLDR
The present review examines the role of carbon nanotubes (CNTs) and nanoparticles in the treatment of breast cancer and the obstacles in the way of nanotechnology in becoming one of the best methods in breast cancer treatment and drug delivery.
Determination of expression profile of p53 gene in different grades of breast cancer tissues by real time PCR
TLDR
The abnormal expression of p53 shows that there are some genetic and epigenetic factors which are the primal cause of an abnormal gene expression and it is recommended to perform next generation sequencing (NGS) of the gene to find out the mutations causing the abnormal behavior of the p53 gene.
Long-term Results of Breast Cancer Treatment in the Elderly and Old Age
The relapse-free and overall survival, after the treatment of breast cancer, in elderly and senile patients, in addition to the time of initial treatment and the stage of the disease, directly
Oncoplastic breast surgery in comparative study with standard conservative breast surgery
TLDR
Oncoplastic BCS can achieve satisfactory results regarding the final aesthetic appearance and tumor control and the latissimus dorsi flap not only is a safe and cosmetic method of reconstruction in this clinical scenario but also is associated with favorable patient-reported outcomes.
Risk Factors in Breast Cancer Progression and Current Advances in Therapeutic Approaches to Knockdown Breast Cancer
TLDR
This review elaborates the different risk factors that lead to breast cancer progression and the current therapeutic approaches ongoing to tackle the tangled cellular behavior of cancerous cell.

References

SHOWING 1-10 OF 52 REFERENCES
MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential
TLDR
Advances from the most recent studies of micro RNAs in one of the most common cancers, breast cancer, are highlighted, especially the functions of specifically selected microRNAs.
Over-expression of Skp2 is associated with resistance to preoperative doxorubicin-based chemotherapy in primary breast cancer
TLDR
Skp2 expression may be a useful marker for predicting response to doxorubicin-based preoperative chemotherapy and clinical outcome in patients with locally advanced breast cancer.
Breast cancer genes: beyond BRCA1 and BRCA2.
TLDR
Additional research in clinical management of moderate and low-risk variants is needed before full implementation of multi-gene panel testing into clinical work-flows, as this review focuses on the different components of familial breast cancer risk.
Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer.
TLDR
Skp2 has oncogenic potential in breast epithelial cells and is overexpressed in a subset of breast carcinomas (ER- and Her-2 negative) for which Skp2 inhibitors may represent a valid therapeutic option.
MicroRNA (miRNA) in cancer
  • K. Reddy
  • Biology, Medicine
    Cancer Cell International
  • 2015
TLDR
This review summarizes: (i) the current understanding of interactions between miRNAs and their target genes, (ii) recent advances in the regulatory mechanisms that control the expression of genes related to carcinogenesis, and (iii) the role of mi RNAs in cancer diagnosis and therapy.
Progression from ductal carcinoma in situ to invasive breast cancer: Revisited
Nanotechnology-based approaches in anticancer research
TLDR
The present review summarizes the application of various nanotechnology-based approaches towards the diagnostics and therapeutics of cancer.
...
...